Table of Contents USA Biopharmaceuticals Market Report 2012-2023 1 Biopharmaceuticals Overview 1.1 Product Overview and Scope of Biopharmaceuticals 1.2 Classification of Biopharmaceuticals by Product Category 1.2.1 USA Biopharmaceuticals Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Biopharmaceuticals Sales (K Units) Market Share by Types in 2017 1.2.3 Monoclonal Antibodies 1.2.4 Interferon 1.2.5 Colony-Stimulating Factor 1.2.6 Erythropoietin 1.2.7 Insulin 1.2.8 Vaccines 1.2.9 ????Growth Hormones 1.2.10 ????Others 1.3 USA Biopharmaceuticals Market by Application/End Users 1.3.1 USA Biopharmaceuticals (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Tumor 1.3.3 Diabetes 1.3.4 Cardiovascular 1.3.5 Hemophilia 1.3.6 Others 1.4 USA Biopharmaceuticals Market by Region 1.4.1 USA Biopharmaceuticals Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Biopharmaceuticals (2012-2023) 1.5.1 USA Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Biopharmaceuticals 2.2 Raw Material Analysis of Biopharmaceuticals 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Biopharmaceuticals 2.4 Other Costs Analysis of Biopharmaceuticals 2.5 Manufacturing Cost Structure Analysis of Biopharmaceuticals 2.6 Manufacturing Process Analysis of Biopharmaceuticals 2.7 Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Biopharmaceuticals Players/Suppliers Profiles and Sales Data 3.1 Roche 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Biopharmaceuticals Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Roche Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Roche Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Roche Biopharmaceuticals Volume in Different Applications and Its Application Share 3.2 Amgen 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Biopharmaceuticals Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Amgen Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Amgen Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 Amgen Biopharmaceuticals Volume in Different Applications and Its Application Share 3.3 AbbVie 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Biopharmaceuticals Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 AbbVie Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 AbbVie Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 AbbVie Biopharmaceuticals Volume in Different Applications and Its Application Share 3.4 Sanofi-Aventis 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Biopharmaceuticals Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Sanofi-Aventis Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Sanofi-Aventis Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 Sanofi-Aventis Biopharmaceuticals Volume in Different Applications and Its Application Share 3.5 Johnson & Johnson 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Biopharmaceuticals Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Johnson & Johnson Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Johnson & Johnson Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 Johnson & Johnson Biopharmaceuticals Volume in Different Applications and Its Application Share 3.6 Pfizer 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Biopharmaceuticals Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Pfizer Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Pfizer Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Pfizer Biopharmaceuticals Volume in Different Applications and Its Application Share 3.7 Novo Nordisk 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Biopharmaceuticals Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Novo Nordisk Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Novo Nordisk Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Novo Nordisk Biopharmaceuticals Volume in Different Applications and Its Application Share 3.8 Eli Lilly 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Biopharmaceuticals Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Eli Lilly Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Eli Lilly Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 Eli Lilly Biopharmaceuticals Volume in Different Applications and Its Application Share 3.9 Novartis 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Biopharmaceuticals Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Novartis Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Novartis Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Novartis Biopharmaceuticals Volume in Different Applications and Its Application Share 3.10 Merck 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Biopharmaceuticals Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Merck Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Merck Different Types of Biopharmaceuticals Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 Merck Biopharmaceuticals Volume in Different Applications and Its Application Share 4 USA Biopharmaceuticals Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Biopharmaceuticals Market Competition by Players/Manufacturers 4.1.1 USA Biopharmaceuticals Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Biopharmaceuticals Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Biopharmaceuticals Sales and Revenue by Type 4.2.1 USA Biopharmaceuticals Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Biopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Biopharmaceuticals Sales and Revenue by Application 4.3.1 USA Biopharmaceuticals Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Biopharmaceuticals Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Biopharmaceuticals Sales (K Units) by Application 5 Northeast Biopharmaceuticals (Sales, Revenue and Price) 5.1 Northeast Biopharmaceuticals Sales and Value (2012-2017) 5.1.1 Northeast Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Biopharmaceuticals Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Biopharmaceuticals Sales (K Units) and Market Share by Type 5.3 Northeast Biopharmaceuticals Sales (K Units) and Market Share by Application 6 Midwest Biopharmaceuticals (Sales, Revenue and Price) 6.1 Midwest Biopharmaceuticals Sales and Value (2012-2017) 6.1.1 Midwest Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Biopharmaceuticals Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Biopharmaceuticals Sales (K Units) and Market Share by Type 6.3 Midwest Biopharmaceuticals Sales (K Units) and Market Share by Application 7 South Biopharmaceuticals (Sales, Revenue and Price) 7.1 South Biopharmaceuticals Sales and Value (2012-2017) 7.1.1 South Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Biopharmaceuticals Revenue and Growth Rate (2012-2017) 7.1.3 South Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Biopharmaceuticals Sales (K Units) and Market Share by Type 7.3 South Biopharmaceuticals Sales (K Units) and Market Share by Application 8 West Biopharmaceuticals (Sales, Revenue and Price) 8.1 West Biopharmaceuticals Sales and Value (2012-2017) 8.1.1 West Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Biopharmaceuticals Revenue and Growth Rate (2012-2017) 8.1.3 West Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Biopharmaceuticals Sales (K Units) and Market Share by Type 8.3 West Biopharmaceuticals Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Biopharmaceuticals Market Forecast (2018-2023) 12.1 USA Biopharmaceuticals Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Biopharmaceuticals Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Biopharmaceuticals Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Biopharmaceuticals Price and Trend Forecast (2018-2023) 12.2 USA Biopharmaceuticals Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Biopharmaceuticals Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Biopharmaceuticals Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Biopharmaceuticals Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Biopharmaceuticals Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Biopharmaceuticals Sales Forecast by Type (2018-2023) 12.3.2 USA Biopharmaceuticals Revenue Forecast by Type (2018-2023) 12.3.3 USA Biopharmaceuticals Price Forecast by Type (2018-2023) 12.4 USA Biopharmaceuticals Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Biopharmaceuticals Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Biopharmaceuticals Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Biopharmaceuticals Sales (K Units) by Application (2016-2023) Figure Product Picture of Biopharmaceuticals Table USA Biopharmaceuticals Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Biopharmaceuticals Sales (K Units) Market Share by Types in 2017 Figure Monoclonal Antibodies Picture Figure Interferon Picture Figure Colony-Stimulating Factor Picture Table USA Biopharmaceuticals Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Biopharmaceuticals by Applications in 2017 Figure Tumor Examples Figure Diabetes Examples Figure Cardiovascular Examples Table USA Market Biopharmaceuticals Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure South Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure West Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2023) Figure USA Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Biopharmaceuticals Table Industry News List of Biopharmaceuticals Figure Industry Chain Structure of Biopharmaceuticals Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Biopharmaceuticals in 2017 Figure Manufacturing Process Analysis of Biopharmaceuticals Table Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2017 Table Major Buyers of Biopharmaceuticals Table Roche Basic Information List Table Roche Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Roche Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Roche Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure Roche Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Roche Biopharmaceuticals Volume in and Its Application Share Table Roche Biopharmaceuticals Volume in and Its Application Share Table Roche Biopharmaceuticals Volume in and Its Application Share Table Amgen Basic Information List Table Amgen Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Amgen Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure Amgen Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen Biopharmaceuticals Volume in and Its Application Share Table Amgen Biopharmaceuticals Volume in and Its Application Share Table Amgen Biopharmaceuticals Volume in and Its Application Share Table AbbVie Basic Information List Table AbbVie Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AbbVie Biopharmaceuticals Sales Growth Rate (2012-2017) Figure AbbVie Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure AbbVie Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AbbVie Biopharmaceuticals Volume in and Its Application Share Table AbbVie Biopharmaceuticals Volume in and Its Application Share Table AbbVie Biopharmaceuticals Volume in and Its Application Share Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi-Aventis Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Sanofi-Aventis Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure Sanofi-Aventis Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi-Aventis Biopharmaceuticals Volume in and Its Application Share Table Sanofi-Aventis Biopharmaceuticals Volume in and Its Application Share Table Sanofi-Aventis Biopharmaceuticals Volume in and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Johnson & Johnson Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure Johnson & Johnson Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson Biopharmaceuticals Volume in and Its Application Share Table Johnson & Johnson Biopharmaceuticals Volume in and Its Application Share Table Johnson & Johnson Biopharmaceuticals Volume in and Its Application Share Table Pfizer Basic Information List Table Pfizer Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Pfizer Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure Pfizer Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Biopharmaceuticals Volume in and Its Application Share Table Pfizer Biopharmaceuticals Volume in and Its Application Share Table Pfizer Biopharmaceuticals Volume in and Its Application Share Table Novo Nordisk Basic Information List Table Novo Nordisk Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novo Nordisk Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Novo Nordisk Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure Novo Nordisk Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novo Nordisk Biopharmaceuticals Volume in and Its Application Share Table Novo Nordisk Biopharmaceuticals Volume in and Its Application Share Table Novo Nordisk Biopharmaceuticals Volume in and Its Application Share Table Eli Lilly Basic Information List Table Eli Lilly Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Eli Lilly Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure Eli Lilly Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly Biopharmaceuticals Volume in and Its Application Share Table Eli Lilly Biopharmaceuticals Volume in and Its Application Share Table Eli Lilly Biopharmaceuticals Volume in and Its Application Share Table Novartis Basic Information List Table Novartis Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Novartis Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure Novartis Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Biopharmaceuticals Volume in and Its Application Share Table Novartis Biopharmaceuticals Volume in and Its Application Share Table Novartis Biopharmaceuticals Volume in and Its Application Share Table Company Merck Basic Information List Table Company Merck Biopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Merck Biopharmaceuticals Sales Growth Rate (2012-2017) Figure Company Merck Biopharmaceuticals Sales USA Market Share (%) (2012-2017) Figure Company Merck Biopharmaceuticals Revenue USA Market Share (%) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Interferon Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colony-Stimulating Factor Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Merck Biopharmaceuticals Volume in and Its Application Share Table Company Merck Biopharmaceuticals Volume in and Its Application Share Table Company Merck Biopharmaceuticals Volume in and Its Application Share Table USA Biopharmaceuticals Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Biopharmaceuticals Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Biopharmaceuticals Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Biopharmaceuticals Sales Share by Players/Manufacturers Table USA Biopharmaceuticals Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Biopharmaceuticals Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Biopharmaceuticals Revenue Market Share (%) Players Figure 2017 USA Biopharmaceuticals Revenue Market Share (%) Players Table USA Biopharmaceuticals Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Biopharmaceuticals Sales Share by Type (2012-2017) Figure Sales Market Share of Biopharmaceuticals by Type (2012-2017) Figure USA Biopharmaceuticals Sales Growth Rate (%) by Type (2012-2017) Table USA Biopharmaceuticals Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Biopharmaceuticals Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Biopharmaceuticals by Type (2012-2017) Figure USA Biopharmaceuticals Revenue Growth Rate by Type (2012-2017) Table USA Biopharmaceuticals Sales (K Units) and Market Share by Regions (2012-2017) Table USA Biopharmaceuticals Sales Share by Regions (2012-2017) Figure Sales Market Share of Biopharmaceuticals by Regions (2012-2017) Figure USA Biopharmaceuticals Sales Market Share by Regions in 2017 Table USA Biopharmaceuticals Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Biopharmaceuticals Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Biopharmaceuticals by Regions (2012-2017) Figure USA Biopharmaceuticals Revenue Market Share by Regions in 2017 Table USA Biopharmaceuticals Sales (K Units) and Market Share by Application (2012-2017) Table USA Biopharmaceuticals Sales Share (%) by Application (2012-2017) Figure USA Biopharmaceuticals Sales Market Share by Application (2012-2017) Figure USA Biopharmaceuticals Sales Market Share by Application (2012-2017) Figure Northeast Biopharmaceuticals Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table Northeast Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table Northeast Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table Northeast Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Figure Midwest Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table Midwest Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table Midwest Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table Midwest Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Figure South Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) Figure South Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table South Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table South Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure South Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table South Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table South Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure South Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Figure West Biopharmaceuticals Sales (K Units) and Growth Rate (2012-2017) Figure West Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Biopharmaceuticals Sales Price (USD/Unit) Trend (2012-2017) Table West Biopharmaceuticals Sales (K Units) by Type (2012-2017) Table West Biopharmaceuticals Sales (K Units) Market Share by Type (2012-2017) Figure West Biopharmaceuticals Sales (K Units) Market Share by Type in 2017 Table West Biopharmaceuticals Sales (K Units) by Applications (2012-2017) Table West Biopharmaceuticals Sales (K Units) Market Share by Applications (2012-2017) Figure West Biopharmaceuticals Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Biopharmaceuticals Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Biopharmaceuticals Price and Trend Forecast (2018-2023) Table USA Biopharmaceuticals Sales (K Units) Forecast by Regions (2018-2023) Figure USA Biopharmaceuticals Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Biopharmaceuticals Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Biopharmaceuticals Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Biopharmaceuticals Revenue Market Share Forecast by Regions (2018-2023) Figure USA Biopharmaceuticals Revenue Market Share Forecast by Regions in 2023 Figure Northeast Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Biopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Biopharmaceuticals Sales (K Units) Forecast by Type (2018-2023) Figure USA Biopharmaceuticals Sales Market Share Forecast by Type (2018-2023) Table USA Biopharmaceuticals Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Biopharmaceuticals Revenue Market Share Forecast by Type (2018-2023) Table USA Biopharmaceuticals Price (USD/Unit) Forecast by Type (2018-2023) Table USA Biopharmaceuticals Sales (K Units) Forecast by Application (2018-2023) Figure USA Biopharmaceuticals Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck